New Drugs and Clinical Trial Rules 2019, What is New? Our Views from Ethical Perspective

Shivaprakash G, Pallavi Lc

Research output: Contribution to journalArticle

Abstract

A good quality research requires the incorporation of good ethical practices throughout the conduct of the study. An efficient Ethics Committee will facilitate such a research at the site, and can achieve the major objective of ICH-GCP (International Conference on Harmonisation -Good Clinical Practice) guidelines. Awareness of the changing rules among the stakeholders of clinical studies will ensure good clinical practice by safeguarding and protecting the rights, safety and well-being of the research participants. The draft of the New Drugs and Clinical Trials Rules was published in the Gazette of India by central government on March 19, 2019. Keeping abreast of the latest rules are essential for the uninterrupted conduct of clinical studies. We sought to give a summary of important changes in the new rules and to assess those rules from ethical perspective.

Original languageEnglish
Pages (from-to)75-76
Number of pages2
JournalThe Journal of the Association of Physicians of India
Volume67
Issue number10
Publication statusPublished - 01-10-2019

Fingerprint

Clinical Trials
Research
Pharmaceutical Preparations
Ethics Committees
Practice Guidelines
India
Safety
Clinical Studies

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{dd1ced842bfe4564a8449af8a3274954,
title = "New Drugs and Clinical Trial Rules 2019, What is New? Our Views from Ethical Perspective",
abstract = "A good quality research requires the incorporation of good ethical practices throughout the conduct of the study. An efficient Ethics Committee will facilitate such a research at the site, and can achieve the major objective of ICH-GCP (International Conference on Harmonisation -Good Clinical Practice) guidelines. Awareness of the changing rules among the stakeholders of clinical studies will ensure good clinical practice by safeguarding and protecting the rights, safety and well-being of the research participants. The draft of the New Drugs and Clinical Trials Rules was published in the Gazette of India by central government on March 19, 2019. Keeping abreast of the latest rules are essential for the uninterrupted conduct of clinical studies. We sought to give a summary of important changes in the new rules and to assess those rules from ethical perspective.",
author = "Shivaprakash G and Pallavi Lc",
year = "2019",
month = "10",
day = "1",
language = "English",
volume = "67",
pages = "75--76",
journal = "The Journal of the Association of Physicians of India",
issn = "0004-5772",
publisher = "Journal of Association of Physicians of India",
number = "10",

}

New Drugs and Clinical Trial Rules 2019, What is New? Our Views from Ethical Perspective. / G, Shivaprakash; Lc, Pallavi.

In: The Journal of the Association of Physicians of India, Vol. 67, No. 10, 01.10.2019, p. 75-76.

Research output: Contribution to journalArticle

TY - JOUR

T1 - New Drugs and Clinical Trial Rules 2019, What is New? Our Views from Ethical Perspective

AU - G, Shivaprakash

AU - Lc, Pallavi

PY - 2019/10/1

Y1 - 2019/10/1

N2 - A good quality research requires the incorporation of good ethical practices throughout the conduct of the study. An efficient Ethics Committee will facilitate such a research at the site, and can achieve the major objective of ICH-GCP (International Conference on Harmonisation -Good Clinical Practice) guidelines. Awareness of the changing rules among the stakeholders of clinical studies will ensure good clinical practice by safeguarding and protecting the rights, safety and well-being of the research participants. The draft of the New Drugs and Clinical Trials Rules was published in the Gazette of India by central government on March 19, 2019. Keeping abreast of the latest rules are essential for the uninterrupted conduct of clinical studies. We sought to give a summary of important changes in the new rules and to assess those rules from ethical perspective.

AB - A good quality research requires the incorporation of good ethical practices throughout the conduct of the study. An efficient Ethics Committee will facilitate such a research at the site, and can achieve the major objective of ICH-GCP (International Conference on Harmonisation -Good Clinical Practice) guidelines. Awareness of the changing rules among the stakeholders of clinical studies will ensure good clinical practice by safeguarding and protecting the rights, safety and well-being of the research participants. The draft of the New Drugs and Clinical Trials Rules was published in the Gazette of India by central government on March 19, 2019. Keeping abreast of the latest rules are essential for the uninterrupted conduct of clinical studies. We sought to give a summary of important changes in the new rules and to assess those rules from ethical perspective.

UR - http://www.scopus.com/inward/record.url?scp=85072787389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072787389&partnerID=8YFLogxK

M3 - Article

C2 - 31571459

AN - SCOPUS:85072787389

VL - 67

SP - 75

EP - 76

JO - The Journal of the Association of Physicians of India

JF - The Journal of the Association of Physicians of India

SN - 0004-5772

IS - 10

ER -